OXT and autism: Here exploratory biological assessments from a completed double-blind, randomized, placebo-controlled study were performed to examine the effects of a four-week course of chronic oxytocin administration (12 IU, twice daily), or placebo, on oxytocinergic function as assessed using salivary oxytocin levels and OXTR DNAm in school-aged children with autism.